These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32659088)

  • 21. Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis.
    Li L; Yang M; Li C; Xue H; Shi M; Liu Y
    Curr Pharm Biotechnol; 2022; 23(14):1637-1646. PubMed ID: 34514987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
    Paul M; Kumar Panda M; Thatoi H
    J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain.
    Kim HH; Hyun JS; Choi J; Choi KE; Jee JG; Park SJ
    Sci Rep; 2018 Jan; 8(1):368. PubMed ID: 29321504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies.
    Agarwal S; Dixit A; Kashaw SK
    J Mol Graph Model; 2020 Jul; 98():107591. PubMed ID: 32234678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening.
    Abbasi M; Sadeghi-Aliabadi H; Hassanzadeh F; Amanlou M
    J Mol Graph Model; 2015 Sep; 61():186-95. PubMed ID: 26277488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding Mechanism of Inhibitors to Heat Shock Protein 90 Investigated by Multiple Independent Molecular Dynamics Simulations and Prediction of Binding Free Energy.
    Yang F; Wang Y; Yan D; Liu Z; Wei B; Chen J; He W
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of Inhibition of Hsp90 Dimerization by Gyrase B Inhibitor Coumermycin A1 (C-A1) Revealed by Molecular Dynamics Simulations and Thermodynamic Calculations.
    Cele FN; Kumalo H; Soliman ME
    Cell Biochem Biophys; 2016 Sep; 74(3):353-63. PubMed ID: 27376828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular docking study, synthesis and biological evaluation of Schiff bases as Hsp90 inhibitors.
    Dutta Gupta S; Snigdha D; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
    Biomed Pharmacother; 2014 Apr; 68(3):369-76. PubMed ID: 24486109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in silico identification of potent anti-cancer agents by targeting the ATP binding site of the N-domain of HSP90.
    Sepehri B; Rezaei M; Ghavami R
    SAR QSAR Environ Res; 2018 Jul; 29(7):551-565. PubMed ID: 30058412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Approach to Inhibit Heat Shock Response as Anticancer Strategy by Coumarine Compounds Containing Thiazole Skeleton.
    Koca İ; Gümüş M; Özgür A; Dişli A; Tutar Y
    Anticancer Agents Med Chem; 2015; 15(7):916-30. PubMed ID: 25846761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiclass comparative virtual screening to identify novel Hsp90 inhibitors: a therapeutic breast cancer drug target.
    Dunna NR; Bandaru S; Akare UR; Rajadhyax S; Gutlapalli VR; Yadav M; Nayarisseri A
    Curr Top Med Chem; 2015; 15(1):57-64. PubMed ID: 25579569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico identification and computational analysis of the nucleotide binding site in the C-terminal domain of Hsp90.
    Roy SS; Kapoor M
    J Mol Graph Model; 2016 Nov; 70():253-274. PubMed ID: 27771574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.
    Rampogu S; Parate S; Parameswaran S; Park C; Baek A; Son M; Park Y; Park SJ; Lee KW
    Comput Biol Chem; 2019 Dec; 83():107113. PubMed ID: 31493740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico design of small peptide-based Hsp90 inhibitor: a novel anticancer agent.
    Gupta UK; Mahanta S; Paul S
    Med Hypotheses; 2013 Nov; 81(5):853-61. PubMed ID: 24018284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).
    Nguyen CT; Ann J; Sahu R; Byun WS; Lee S; Nam G; Park HJ; Park S; Kim YJ; Kim JY; Seo JH; Lee J
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127374. PubMed ID: 32738983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.